Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Shares Outstanding (Weighted Average) (2020 - 2025)

LifeStance Health (LFST) has disclosed Shares Outstanding (Weighted Average) for 5 consecutive years, with $379.1 million as the latest value for Q4 2024.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 3.18% to $379.1 million in Q4 2024 year-over-year; TTM through Dec 2024 was $379.1 million, a 3.18% increase, with the full-year FY2024 number at $379.1 million, up 3.18% from a year prior.
  • Shares Outstanding (Weighted Average) was $379.1 million for Q4 2024 at LifeStance Health, roughly flat from $380.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $380.4 million in Q3 2024 to a low of $300799.0 in Q3 2020.
  • A 5-year average of $201.4 million and a median of $326.3 million in 2020 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): tumbled 99.89% in 2021, then surged 108374.21% in 2022.
  • LifeStance Health's Shares Outstanding (Weighted Average) stood at $300799.0 in 2020, then rose by 8.88% to $327523.0 in 2021, then soared by 108374.21% to $355.3 million in 2022, then increased by 3.43% to $367.5 million in 2023, then rose by 3.18% to $379.1 million in 2024.
  • Per Business Quant, the three most recent readings for LFST's Shares Outstanding (Weighted Average) are $379.1 million (Q4 2024), $380.4 million (Q3 2024), and $377.9 million (Q2 2024).